DNTH

Conviction 91HealthcareScan · Fri, Jun 26, 2026

DNTH$95.49+4.28%

ResistanceSupportVol 14Insider sell

Vol MA14 1.87M

Mar 27Apr 15May 4May 20Jun 9Jun 26

Dianthus Therapeutics, Inc. /DE/PHARMACEUTICAL PREPARATIONSwww.dianthustx.com ↗

Price95.49

Change+4.28%

Gap+0.94%

Rel volume5.64×

Avg volume1.57M

Avg $ vol134.66M

SMA 2084.65

SMA 5086.61

SMA 20059.01

Price vs 50+10.26%

Price vs 200+61.82%

MA stackbullish

50/200 cross—

Supertrendup · 76.09

RSI (14)64

MACD hist1.56

MACD crossbull · 4d

Stoch %K / %D96 / 92

ADX (14)18

+DI / −DI23 / 16

RSI divergence—

MACD divergence—

ATR %+5.78%

ADR %6.35%

52w high95.76

52w low17.63

From 52w high-0.28%

Above 52w low+441.63%

New 52w highYes

SqueezeOff

Bollinger width24.61%

%B1.02

Donchian pos96.28%

Donchian high96.52

Donchian low68.85

AVWAP (52w high)93.54

vs AVWAP high+2.08%

AVWAP (52w low)57.88

vs AVWAP low+64.98%

OBV trendUp

Chaikin MF (20)0.28

Today vs 20d5.64×

Avg vol (14d)1.87M

Avg vol (20d)1.57M

Avg $ vol (20d)134.66M

Market cap—

RS 3m (vs SPY)+3.23%

RS 6m (vs SPY)+101.98%

RS line new highNo

Trend template8/8

Technical rank91.3

1 week+15.76%

1 month+10.18%

3 months+15.82%

6 months+124.10%

1 year+420.67%

YTD+140.65%

P/E-30.85

P/B4.17

P/S—

P/FCF-38.71

EPS-4.20

Div yield—

ROE-13.51%

ROA-13.02%

Debt/Eq—

Current29.25

EV/EBITDA-24.89

Gross margin—

Net margin—

Rev growth-67.35%

EPS growth-91.05%

Price target130.63

Target upside42.60%

Analyst ratingBuy

Institutional118.05%

Ent. value4.38B

Revenue396K

Net income-40.83M

Gross profit—

Free cash flow-129.37M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out54.67M

Employees92

ListedTue, Sep 12, 2023

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA+

Conviction91 / 100

Pattern quality—

Tech rank91.3 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance92.71

Support74.58

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in DNTH

All disclosures →

No recent disclosed trades by Congress in DNTH. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in DNTH · 2 buys · 8 sells

Insider	Side	Shares	Value	Traded	Filed
Veness Adam M SVP, General Counsel and Sec. · Common Stock · 2026-06-17	Exercise	30K	$536K	2026-06-17	2026-06-18
Veness Adam M SVP, General Counsel and Sec. · Common Stock · 2026-06-17	Sell	16.77K	$1.3M	2026-06-17	2026-06-18
Veness Adam M SVP, General Counsel and Sec. · Common Stock · 2026-06-17	Sell	13.23K	$1.1M	2026-06-17	2026-06-18
Veness Adam M SVP, General Counsel and Sec. · Stock Option (Right to Buy) · 2026-06-17	Exercise	30K	—	2026-06-17	2026-06-18
Randhawa Simrat EVP, Head of R&D · Stock Option (Right to Buy) · 2026-06-01	Exercise	9.38K	$0	2026-06-01	2026-06-02
Randhawa Simrat EVP, Head of R&D · Stock Option (Right to Buy) · 2026-06-01	Exercise	4K	$0	2026-06-01	2026-06-02
Randhawa Simrat EVP, Head of R&D · Common Stock · 2026-06-01	Exercise	6.25K	$136K	2026-06-01	2026-06-02
Randhawa Simrat EVP, Head of R&D · Stock Option (Right to Buy) · 2026-06-01	Exercise	6.91K	$0	2026-06-01	2026-06-02
Randhawa Simrat EVP, Head of R&D · Stock Option (Right to Buy) · 2026-06-01	Exercise	6.25K	$0	2026-06-01	2026-06-02
Randhawa Simrat EVP, Head of R&D · Common Stock · 2026-06-01	Sell	4.16K	$380K	2026-06-01	2026-06-02

SEC filings

EDGAR filings in DNTH · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.